Document:

EX-10.28

 Exhibit 10.28 
 [Execution Copy] 
 MANAGEMENT UNIT SUBSCRIPTION AGREEMENT

 (Class B Units) 
 THIS MANAGEMENT UNIT SUBSCRIPTION AGREEMENT (this “Agreement”) by and between BP Healthcare Holdings LLC, a Delaware limited liability company (the “Company”), and Norman
C. Payson, M.D. (“Advisor”) is made as of November 29, 2012. 
 WHEREAS, on the terms and subject to the
conditions hereof, Advisor desires to subscribe for and acquire from the Company, and the Company desires to issue and provide to Advisor, 3,830,365 of the Company’s Class B Units (the “Units”); and 

WHEREAS, this Agreement is one of several agreements being entered into by the Company or its Affiliates with certain persons who are or
will be key employees or advisors of the Company or one or more Subsidiaries (collectively with Advisor, the “Management Investors”) as part of a management equity purchase plan designed to comply with Regulation D or Rule 701, as
applicable, promulgated under the Securities Act (as defined below); 
 NOW, THEREFORE, in order to implement the foregoing and
in consideration of the mutual representations, warranties, covenants and agreements contained herein, the parties hereto agree as follows: 
  

	1.	Definitions. 

 1.1
Advisor. The term “Advisor” shall have the meaning set forth in the preface. 
 1.2 Advisor’s
Group. The term “Advisor’s Group” means any Permitted Transferee of Advisor that holds Units. 
 1.3
Affiliate. An “Affiliate” of, or Person “Affiliated” with, a specified Person shall mean a Person that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under
common control with, the Person specified. 
 1.4 Agreement. The term “Agreement” shall have the meaning set
forth in the preface. 
 1.5 Blackstone. The term “Blackstone” means Blackstone Capital Partners V L.P. and its
Affiliates. 
 1.6 Board. The “Board” shall mean the Company’s Board of Directors. 

1.7 Cause. The term “Cause” shall mean (A) Advisor’s willful and continued failure to substantially perform
Advisor’s duties to the Company or any of its Subsidiaries or Affiliates (other than as a result of total or partial incapacity due to physical or mental illness or as a result of Advisor resigning as an Advisor to Apria) which failure has
continued for a period of at least 20 days following delivery to Advisor of written demand by the Company or any of its 

  
 1 

 
Subsidiaries or Affiliates specifying the manner in which Advisor has willfully failed to so perform; (B) Advisor’s engagement in fraud or willful dishonesty (other than dishonesty that
has no material detrimental impact on the reputation or business of the Company and its Affiliates); (C) any act on the part of Advisor that constitutes a felony (other than traffic offenses), or its equivalent under applicable non-U.S. law
(provided that if Advisor’s services employment is terminated for “Cause” as a result of any such act, but is not convicted in respect of, and does not plead guilty or nolo contendere to, the applicable conduct before a court of
competent jurisdiction, then the Company shall have the burden of establishing by clear and convincing evidence that such conduct occurred and could reasonably be expected to have a material detrimental impact on the reputation or business of the
Company and its Affiliates (and the failure to so satisfy such burden shall result in the termination of Advisor’s employment being without Cause) or (D) Advisor’s material breach of the provisions of Appendix A hereto;
provided, further, that “Cause” shall cease to exist for an event on the 90th day following the later of its occurrence or the knowledge thereof by a majority of the Board, unless the Company or any of its Subsidiaries or
Affiliates has given Advisor written notice thereof prior to such date. A termination of Advisor shall not be deemed with Cause unless and until there shall have been delivered to Advisor a copy of a finding duly approved by a majority of the entire
membership of the Board (not including Advisor), concluding that, in the good faith opinion of such majority, Advisor has engaged in the conduct described in one or more of the clauses above, specifying the particulars thereof in reasonable detail
and demonstrating that no cure by Advisor was effected following giving Advisor 20 days to cure the negative impact of such conduct after written notice by the Company or any of its Subsidiaries or Affiliates to Advisor of such conduct, or, in the
Board’s good faith reasonable judgment, no cure was possible. 
 1.8 Change of Control. The term “Change of
Control” shall have the meaning set forth in either the LLC Agreement or the Amended and Restated Limited Liability Company Agreement of Apria Holdings LLC, as it may be amended or supplemented thereafter from time to time. 

1.9 Closing. The term “Closing” shall have the meaning set forth in Section 2.2. 

1.10 Closing Date. The term “Closing Date” shall have the meaning set forth in Section 2.2. 

1.11 Company. The term “Company” shall have the meaning set forth in the preface. 

1.12 Constructive Termination. The term “Constructive Termination” shall be deemed to have occurred upon (A) the
failure of the Company or its Subsidiaries to pay or cause to be paid Advisor’s fees and reimbursable expenses (in each case, if any) when due under the Services Agreement; (B) a reduction in such fees or reimbursable expenses under the
Services Agreement or (C) any material breach by the Company or its Subsidiaries or any material agreement with Advisor; provided that none of these events shall constitute Constructive Termination unless the Company fails to cure such
event within 30 days after receipt from Advisor of written notice specifying in reasonable detail the event which constitutes Constructive Termination; provided, further, that “Constructive Termination” shall cease to exist
for an event on the 90th day following the later of its occurrence or Advisor’s knowledge thereof, unless Advisor has given the Company written notice thereof prior to such date. 

  
 2 

 1.13 Employee and Employment. The term “employee” shall mean,
without any inference as to negate Advisor’s status as a member of the Company for all purposes hereunder (subject to the terms hereof) and for federal and other tax purposes, any employee (as defined in accordance with the regulations and
revenue rulings then applicable under Section 3401(c) of the Internal Revenue Code of 1986, as amended) of the Company or any of its Subsidiaries, and the term “employment” shall include service as a part- or full-time employee
or advisor or board member to the Company or any of its Subsidiaries. 
 1.14 LLC Agreement. The term “LLC
Agreement” shall have the meaning set forth in the Securityholders Agreement. 
 1.15 Management Investors. The term
“Management Investors” shall have the meaning set forth in the preface. 
 1.16 Permitted Transferee. The term
“Permitted Transferee” means any Person to whom Advisor transfers Units in accordance with the Securityholders Agreement (other than the Sponsor and the Company and their respective Affiliates and except for transfers pursuant to a Public
Offering). 
 1.17 Person. The term “Person” shall mean any individual, corporation, partnership, limited
liability company, trust, joint stock company, business trust, unincorporated association, joint venture, governmental authority or other entity of any nature whatsoever. 
 1.18 Public Offering. The term “Public Offering” shall have the meaning set forth in the Securityholders Agreement. 

1.19 Securities Act. The term “Securities Act” shall mean the Securities Act of 1933, as amended, and all rules and
regulations promulgated thereunder, as the same may be amended from time to time. 
 1.20 Securityholders Agreement. The
term “Securityholders Agreement” shall mean the Securityholders Agreement among the Sponsor, one or more Management Investors and the Company, as it may be amended or supplemented thereafter from time to time. 

1.21 Sponsor. The term “Sponsor” means Blackstone. 

1.22 Subsidiary. The term “Subsidiary” means any corporation, limited liability company, partnership or other entity
with respect to which another specified entity has the power to vote or direct the voting of sufficient securities to elect directors (or comparable authorized persons of such entity) having a majority of the voting power of the board of directors
(or comparable governing body) of such entity. 
 1.23 Termination Date. The term “Termination Date” means the
date upon which Advisor’s employment with the Company and its Subsidiaries is terminated. 
 1.24 Unvested Units.
The term “Unvested Units” means, with respect to Advisor’s Class B Units granted pursuant to this Agreement, the number of such Units that are not “Vested Units”. 

  
 3 

 1.25 Vested Units. The term “Vested Units” shall mean, with respect to an
Advisor’s Class B Units granted pursuant to this Agreement, the number of such Units that are vested, as determined in accordance with Schedule I attached hereto. The Board may elect at any time to treat Units as Vested Units by resolution.

 1.26 Vesting Reference Date. The term “Vesting Reference Date” shall mean, November 29, 2012.

  

	2.	Subscription for and Grant of Units; Forfeiture. 

 2.1 Grant of Units. Pursuant to the terms and subject to the conditions set forth in this Agreement, Advisor hereby subscribes for and agrees to acquire, and the Company hereby agrees to issue and
award to Advisor on the Closing Date, 3,830,365 Class B Units in exchange for services performed for the Company and its Subsidiaries by Advisor. Notwithstanding anything to the contrary in the LLC Agreement, Executive’s initial distributions
in respect of each Class B Unit granted pursuant to this Agreement (whether or not then vested) shall be foregone and shall instead be distributed in respect of other Units until such time as the cumulative foregone distributions in respect of each
such Class B Unit equals $0.10 (the “Delayed Amount Per Class B Unit”). Once the Delayed Amount Per Class B Unit has been foregone, Executive shall then be entitled to receive 100% of all subsequent distributions to holders of Units until
Executive shall have received distributions in respect of this sentence per Class B Unit equal to the Delayed Amount Per Class B Unit. Thereafter, Executive shall be entitled to receive distributions in connection with each Class B Unit calculated
in the same manner as other Class B Units. The intent of the foregoing exclusion is to ensure that the Class B Units do not participate in a distribution of any profits or increase in the value of the Company created prior to the Closing Date, such
that the Class B Units qualify as “profits interests” on the date of the conversion under applicable tax laws. 
 2.2
The Closing. The closing (the “Closing”) of the grant of Units hereunder shall take place on November 30, 2012. The date of the Closing shall be the “Closing Date”. 

2.3 Section 83(b) Election. Within 10 days after the Closing, Advisor shall provide the Company with a copy of a completed
election under Section 83(b) of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder in the form of Exhibit A. Advisor shall timely (within 30 days of the Closing) file (via certified mail, return receipt
requested) such election with the Internal Revenue Service and shall thereafter notify the Company it has made such timely filing. Advisor should consult his tax advisor regarding the consequences of a Section 83(b) election, as well as the
receipt, vesting, holding and sale of Units. 
 2.4 Closing Conditions. Notwithstanding anything in this Agreement to
the contrary, the Company shall be under no obligation to issue or grant to Advisor any Units unless (i) Advisor is an employee of, or advisor or consultant to, the Company or one of its Subsidiaries on the Closing Date; (ii) the
representations of Advisor contained in Section 3 hereof are true and correct in all material respects as of the Closing Date and (iii) Advisor is not in breach of any agreement, obligation or covenant herein required to be performed or
observed by Advisor on or prior to the Closing Date. 

  
 4 

 2.5 Termination; Forfeiture of Units. If Advisor’s employment with the Company
and its Subsidiaries is terminated for any reason, all Unvested Units will be forfeited (whether held by Advisor or Advisor’s Group). In addition, if Advisor’s employment with the Company and its Subsidiaries is terminated by the Company
or any of its Subsidiaries with Cause (or by Advisor when grounds exist for a termination by the Company or any of its Subsidiaries with Cause), all Vested Units also will be forfeited (whether held by Advisor or Advisor’s Group). 

 

	3.	Investment Representations and Covenants of Advisor and Representations of the Company. 

3.1 Units Unregistered. Advisor acknowledges and represents that Advisor has been advised by the Company that: 

(a) the offer and sale of the Units have not been registered under the Securities Act; 

(b) the Units must be held indefinitely and Advisor must continue to bear the economic risk of the investment in the Units unless the
offer and sale of such Units are subsequently registered under the Securities Act and all applicable state securities laws or an exemption from such registration is available (or as otherwise provided in the Securityholders Agreement); 

(c) there is no established market for the Units and it is not anticipated that there will be any public market for the Units in the
foreseeable future; 
 (d) a restrictive legend in the form set forth below and the legends set forth in Section 7.3(a) and
(b) of the Securityholders Agreement shall be placed on the certificates, if any, representing the Units: 
 “THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN REPURCHASE OPTIONS AND OTHER PROVISIONS SET FORTH IN A MANAGEMENT UNITS SUBSCRIPTION AGREEMENT WITH THE ISSUER, AS AMENDED AND MODIFIED FROM TIME TO TIME, A COPY OF WHICH MAY BE
OBTAINED BY THE HOLDER HEREOF AT THE ISSUER’S PRINCIPAL PLACE OF BUSINESS WITHOUT CHARGE”; and 
 (e) a notation shall
be made in the appropriate records of the Company indicating that the Units are subject to restrictions on transfer and, if the Company should at some time in the future engage the services of a securities transfer agent, appropriate stop-transfer
instructions will be issued to such transfer agent with respect to the Units. 
 3.2 Additional Investment
Representations. Advisor represents and warrants that: 
 (a) Advisor’s financial situation is such that Advisor can
afford to bear the economic risk of holding the Units for an indefinite period of time, has adequate means for providing for Advisor’s current needs and personal contingencies, and can afford to suffer a complete loss of Advisor’s
investment in the Units; 

  
 5 

 (b) Advisor’s knowledge and experience in financial and business matters are such that
Advisor is capable of evaluating the merits and risks of the investment in the Units; 
 (c) Advisor understands that the Units
are a speculative investment which involves a high degree of risk of loss of Advisor’s investment therein, there are substantial restrictions on the transferability of the Units and, on the Closing Date and for an indefinite period following
the Closing, there will be no public market for the Units and, accordingly, it may not be possible for Advisor to liquidate Advisor’s investment in case of emergency, if at all; 

(d) Advisor understands and has taken cognizance of all the risk factors related to the purchase of the Units and, other than as set
forth in this Agreement, no representations or warranties have been made to Advisor or Advisor’s representatives concerning the Units or the Company or their prospects or other matters; 

(e) Advisor has been given the opportunity to examine all documents and to ask questions of, and to receive answers from, the Company and
its representatives concerning the Company and its Subsidiaries, the Securityholders Agreement, the Company’s organizational documents and the terms and conditions of the purchase of the Units and to obtain any additional information which
Advisor deems necessary; 
 (f) all information which Advisor has provided to the Company and the Company’s representatives
concerning Advisor and Advisor’s financial position is complete and correct in all material respects as of the date of this Agreement; and 
 (g) Advisor is an “accredited investor” within the meaning of Rule 501(a) under the Securities Act. 
 3.3 Other Representations. Advisor acknowledges that Blackstone and its Affiliates may, from time to time, provide services to the Company and its Affiliates for which a fee will be paid by the
Company or its Affiliates, including an annual monitoring/advisory fee. 
 3.4 Representations and Warranties of the
Company. 
 (a) Organization. The Company (i) is a limited liability company duly organized, validly existing
and in good standing under the laws of the State of Delaware and (ii) has the requisite power and authority to own or lease and operate its assets and carry on its business. 

(b) Authorization. The Company (or its applicable Affiliate) has the requisite power and authority to enter into this Agreement
and the Services Agreement dated as of the date hereof between Advisor, the Company, Holdings and Apria (the “Services Agreement”) (together with the LLC Agreement and the Securityholders Agreement, the “Transaction
Documents”). The execution, delivery and performance by the Company of this Agreement and the Services Agreement and the consummation by the Company of the transactions contemplated hereby and thereby have been duly authorized by all
necessary action on the part of the Company. 
 (c) Due Issuance and Authorization of Units. The Units being issued
pursuant to this Agreement have been duly authorized and upon issuance in accordance with the terms of this Agreement, will be duly authorized, validly issued, fully paid and nonassessable (to the extent such concepts are legally applicable to
membership interests in a Delaware limited liability company). 

  
 6 

	4.	Competitive Activity. Advisor acknowledges and recognizes the highly competitive nature of the businesses of the Company and its Affiliates and accordingly
agrees, in his capacity as an investor and equityholder in the Company and its Affiliates, to the provisions of Appendix A to this Agreement. 

  

	5.	Miscellaneous. 

 5.1
Transfers. Prior to the transfer of Units to a Permitted Transferee, Advisor shall deliver to the Company a written agreement of the proposed transferee (a) evidencing such Person’s undertaking to be bound by the terms of this Agreement
and (b) acknowledging that the Units transferred to such Person will continue to be Units for purposes of this Agreement in the hands of such Person. Any transfer or attempted transfer of Units in violation of any provision of this Agreement or the
Securityholders Agreement shall be void, and the Company shall not record such transfer on its books or treat any purported transferee of such Units as the owner of such Units for any purpose. 

5.2 Recapitalizations, Exchanges, Etc., Affecting Units. The provisions of this Agreement shall apply, to the full extent set
forth herein with respect to the Units, to any and all securities of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of, in exchange for, or in
substitution of the Units, by reason of any dividend payable in Units, issuance of Units, combination, recapitalization, reclassification, merger, consolidation or otherwise. 
 5.3 Advisor’s Engagement by the Company. Nothing contained in this Agreement shall be deemed to obligate the Company or any Subsidiary of the Company to engage or retain Advisor in any
capacity whatsoever or to prohibit or restrict the Company (or any such Subsidiary) from terminating the services of Advisor at any time or for any reason whatsoever, with or without Cause. 

5.4 Cooperation. Advisor agrees to cooperate with the Company in taking action reasonably necessary to consummate the transactions
contemplated by this Agreement. 
 5.5 Binding Effect. The provisions of this Agreement shall be binding upon and accrue
to the benefit of the parties hereto and their respective heirs, legal representatives, successors and assigns; provided, however, that no Transferee shall derive any rights under this Agreement unless and until such Transferee has
executed and delivered to the Company a valid undertaking and becomes bound by the terms of this Agreement; and provided further that the Sponsor is a third party beneficiary of this Agreement and shall have the right to enforce the
provisions hereof. 

  
 7 

 5.6 Amendment; Waiver. This Agreement may be amended only by a written instrument
signed by the parties hereto. No waiver by any party hereto of any of the provisions hereof shall be effective unless set forth in a writing executed by the party so waiving. 
 5.7 Governing Law; Jurisdiction. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware applicable to contracts made and to be performed
therein. Any suit, action or proceeding with respect to this Agreement, or any judgment entered by any court in respect of any thereof, shall be brought in any court of competent jurisdiction in the State of New York or the State of Delaware, and
each of the Company and the members of Advisor’s Group hereby submits to the exclusive jurisdiction of such courts for the purpose of any such suit, action, proceeding or judgment. Each of the members of Advisor’s Group and the Company
hereby irrevocably waives (i) any objections which it may now or hereafter have to the laying of the venue of any suit, action or proceeding arising out of or relating to this Agreement brought in any court of competent jurisdiction in the
State of Delaware or the State of New York, (ii) any claim that any such suit, action or proceeding brought in any such court has been brought in any inconvenient forum and (iii) any right to a jury trial. 

5.8 Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given when
delivered by hand or overnight courier or three postal delivery days after it has been mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth below in this Agreement, or to
such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 

(a) If to the Company: 
 BP Healthcare Holdings LLC 
 345 Park Avenue 

New York, NY 10154 
 Attention: Neil P. Simpkins 
 with a copy (which shall not constitute notice) to:

 The Blackstone Group 
 345 Park Avenue 
 New York, NY 10154 

Attention: Neil P. Simpkins 
 and 
 Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 
 New York, NY 10017-3954 
 Attention: Gregory T. Grogan 

If to Advisor: 

Norman C. Payson 

NCP, Inc., Suite 3 
 8 Centre Street 
 Concord, NH 03301 

  
 8 

 with a copy to: 
 Skadden Arps Slate Meagher & Flom LLP 
 Four Times Square 

New York, New York 10036 

	 	Attention:	Paul T. Schnell 

	 	 	Neil P. Stronski 

 5.9
Integration. This Agreement and the documents referred to herein or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to the subject matter hereof and thereof. There are no
restrictions, agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein and therein. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter; provided that this Agreement does not modify, amend or supersede the Management Unit Subscription Agreement by and between the Company and Advisor, dated November 21, 2008.

 5.10 Counterparts. This Agreement may be executed in separate counterparts, and by different parties on separate
counterparts each of which shall be deemed an original, but all of which shall constitute one and the same instrument. 
 5.11
Injunctive Relief. The Company, Advisor and Advisor’s Permitted Transferees each acknowledges and agrees that a violation of any of the terms of this Agreement will cause the Company, Advisor or Advisor’s Permitted Transferees, as
the case may be, irreparable injury for which adequate remedy at law is not available. Accordingly, it is agreed that the Company, Advisor or Advisor’s Permitted Transferees may seek an injunction, restraining order or other equitable relief to
prevent breaches of the provisions of this Agreement and to enforce specifically the terms and provisions hereof in any court of competent jurisdiction in the United States or any state thereof, in addition to any other remedy to which it may be
entitled at law or equity. 
 5.12 Rights Cumulative; Waiver. The rights and remedies of Advisor and the Company under
this Agreement shall be cumulative and not exclusive of any rights or remedies which either would otherwise have hereunder or at law or in equity or by statute, and no failure or delay by either party in exercising any right or remedy shall impair
any such right or remedy or operate as a waiver of such right or remedy, nor shall any single or partial exercise of any power or right preclude such party’s other or further exercise or the exercise of any other power or right. The waiver by
any party hereto of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any preceding or succeeding breach and no failure by either party to exercise any right or privilege hereunder shall be deemed a waiver
of such party’s rights or privileges hereunder or shall be deemed a waiver of such party’s rights to exercise the same at any subsequent time or times hereunder. 
 *    *    *    *    * 

  
 9 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the date
first above written. 
  

	
	 

	Norman C. Payson, M.D.

  
 10 

 
					
	BP HEALTHCARE HOLDINGS LLC
		
	By:	 	 

		 	Name:	 	Neil Simpkins
		 	Title:	 	

  
 11 

 SCHEDULE I 
 Vesting of Units 
 Initially, all Units will be Unvested Units. The percentage of
the Units that will be Vested Units in respect of a Termination Date occurring: 
  

	 	•	 	 prior to 3 months after the Vesting Reference Date, will be 0% 

 

	 	•	 	 on or after 3 months after the Vesting Reference Date, but prior to 6 months after the Vesting Reference Date, will be 6.25%

  

	 	•	 	 on or after 6 months after the Vesting Reference Date, but prior to 9 months after the Vesting Reference Date, will be 12.5%

  

	 	•	 	 on or after 9 months after the Vesting Reference Date, but prior to 12 months after the Vesting Reference Date, will be 18.75%

  

	 	•	 	 on or after 12 months after the Vesting Reference Date, but prior to 15 months after the Vesting Reference Date, will be 25%

  

	 	•	 	 on or after 15 months after the Vesting Reference Date, but prior to 18 months after the Vesting Reference Date, will be 31.25%

  

	 	•	 	 on or after 18 months after the Vesting Reference Date, but prior to 21 months after the Vesting Reference Date, will be 37.5%

  

	 	•	 	 on or after 21 months after the Vesting Reference Date, but prior to 24 months after the Vesting Reference Date, will be 43.75%

  

	 	•	 	 on or after 24 months after the Vesting Reference Date, but prior to 27 months after the Vesting Reference Date, will be 50%

  

	 	•	 	 on or after 27 months after the Vesting Reference Date, but prior to 30 months after the Vesting Reference Date, will be 56.25%

  

	 	•	 	 on or after 30 months after the Vesting Reference Date, but prior to 33 months after the Vesting Reference Date, will be 62.50%

  

	 	•	 	 on or after 33 months after the Vesting Reference Date, but prior to 36 months after the Vesting Reference Date, will be 68.75%

  

	 	•	 	 on or after 36 months after the Vesting Reference Date, but prior to 39 months after the Vesting Reference Date, will be 75%

  

	 	•	 	 on or after 39 months after the Vesting Reference Date, but prior to 42 months after the Vesting Reference Date, will be 81.25%

	 	•	 	 on or after 42 months after the Vesting Reference Date, but prior to 45 months after the Vesting Reference Date, will be 87.5%

  

	 	•	 	 on or after 45 months after the Vesting Reference Date, but prior to 48 months after the Vesting Reference Date, will be 93.75%

  

	 	•	 	 on or after 48 months after the Vesting Reference Date, will be 100%; 

 Notwithstanding the foregoing, immediately prior to, and following, the occurrence of a Change of Control that occurs prior to the Termination Date, 100% of the Time-Vesting Units that are Unvested Units
shall become Vested Units; 
 Except as provided in the immediately preceding sentence, any Units that are Unvested Units on a Termination Date
shall be immediately forfeited by Advisor. 

  
 I-2

 Appendix A 

Restrictive Covenants 
  

	 	1.	Confidentiality; Non-Compete; Non-Solicit. 

 (a) For the purposes of this Appendix A, any reference to the “Company” shall mean the Company and its Subsidiaries, collectively. In view of the fact that Advisor’s work for the Company
brings Advisor into close contact with many confidential affairs of the Company not readily available to the public, and plans for further developments, Advisor agrees: 

(i) to keep and retain in the strictest confidence all confidential matters of the Company, including, without limitation,
“know how,” trade secrets, customer lists, pricing policies, operational methods, technical processes, formulae, inventions and research projects, and other business affairs of the Company, learned by Advisor heretofore or hereafter, and
not to disclose them to anyone outside of the Company or its representatives, agents or advisors, either during or after Advisor’s services with the Company, except as required by applicable law , in the course of performing Advisor’s
duties hereunder or with the Company’s express consent; and 
 (ii) to deliver promptly to the Company on
termination of Advisor’s services by the Company, or at any time the Company may so request, all memoranda, notes, records, reports, manuals, drawings, blueprints and other documents (and all copies thereof) relating to the Company’s
business and all property associated therewith, which Advisor may then possess or have under Advisor’s control; 
 provided that the
foregoing shall not apply to information that was or becomes generally available to the public prior to, and other than as a result of, disclosure by Advisor. 
 (b) During the period of Advisor’s services and, following termination of such services for any reason, for 12 months following the date of such termination, (i) Advisor shall not, directly or
indirectly, enter the employ of, or render any services to, any person, firm or corporation engaged in any business that competes with a material line of business of Holdings or its Subsidiaries (subject to the following proviso, the
“Business”) at any time; provided that for periods after the Termination Date, “material line of business” will be determined as of the Termination Date; (ii) Advisor shall not engage in the Business on Advisor’s
own account; (iii) Advisor shall not invest in any such Business, directly or indirectly, as an individual, partner, shareholder, principal, member, trustee or similar capacity and (iv) Advisor shall not solicit or assist in soliciting in
competition with Company in the Business, the business of any then current or prospective client or former customer with whom Advisor (or his direct reports) had personal contact or dealings on behalf of the Company; provided, however,
that nothing contained in this Section 1(b) shall be deemed to prohibit (i) Advisor’s involvement in any capacity in any health plan, health insurance business or health care financing business, (ii) Advisor from acquiring,
solely as an investment, up to five percent (5%) of the outstanding shares of capital stock of any public corporation or (iii) Advisor’s passive investments in existence as of the date hereof. 

 (c) During the period of Advisor’s services and, following termination of such services
for any reason, for 24 months following the date of such termination, Advisor shall not, directly or indirectly: 

(i) solicit or encourage any manager or executive of the Company to leave the employment or engagement of the Company; or

 (ii) hire any manager or executive of the Company who was employed by the Company as of the date of
Advisor’s termination of services with the Company or who left the services of the Company coincident with, or within one year prior to, the termination of Advisor’s services with the Company. 

provided, however, that (x) the foregoing clause 1(c)(i) shall not preclude Advisor from (A) making good faith generalized
solicitations for employees through advertisements or search firms and hiring any persons through such solicitations if Advisor was not aware of such person’s prior employment with the Company; provided, that Advisor does not encourage
or advise such firm to approach any such employee and such searches are not targeted or focused on the Company’s employees, or (B) responding to or hiring any employee of the Company who contacts Advisor at his or her own initiative
without any prior direct or indirect encouragement or solicitation from Advisor if Advisor was not aware of such person’s prior employment with the Company and (y) the foregoing paragraph 1(c) shall not apply with respect to the
solicitation or hiring on or after January 1, 2014 of any Person who is a resident of New Hampshire (provided that conduct that would otherwise be prohibited by paragraph 1(c) did not occur prior to such date). 

(d) If Advisor commits a breach, or threatens to commit a breach, of any of the provisions of Section 1 hereof, the Company shall
have the following rights and remedies: 
 (i) the right and remedy to have the provisions of this Appendix
specifically enforced by any court having equity jurisdiction, it being acknowledged and agreed that any such breach or threatened breach will cause irreparable injury to the Company and that money damages will not provide an adequate remedy to the
Company; and 
 (ii) the right and remedy to require Advisor to account for and pay over to the Company all
compensation, profits, monies, accruals, increments or other benefits (collectively, “Benefits”) derived or received by Advisor as the result of any transactions constituting a breach of any of the provisions of this Section 1,
and Advisor hereby agrees to account for and pay over such Benefits to the Company. 
 Each of the rights and remedies enumerated above shall be
independent of the other, and shall be severally enforceable, and all of such rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or in equity. 

(e) If any of the covenants contained in Section 1 or any part thereof, hereafter are construed to be invalid or unenforceable, the
same shall not affect the remainder of the covenant or covenants, which shall be given full effect, without regard to the invalid portions. 

  
 A-2

 (f) If any of the covenants contained in Section 1, or any part thereof, are held to be
unenforceable because of the duration of such provision or the area covered thereby, the parties agree that the court making such determination shall have the power to reduce the duration and/or area of such provision and, in its reduced form, said
provision shall then be enforceable. 
 (g) The parties hereto intend to and hereby confer jurisdiction to enforce the covenants
contained in Section 1 upon the courts of any state within the geographical scope of such covenants. In the event that the courts of any one or more of such states shall hold such covenants wholly unenforceable by reason of the breadth of such
covenants or otherwise, it is the intention of the parties hereto that such determination not bar or in any way affect the Company’s right to the relief provided above in the courts of any other states within the geographical scope of such
covenants as to breaches of such covenants in such other respective jurisdictions, the above covenants as they relate to each state being for this purpose severable into diverse and independent covenants. 

(h) It is expressly understood and agreed that although Advisor and the Company consider the restrictions contained in this
Section 1 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Appendix A is an unenforceable restriction against Advisor, the
provisions of this Appendix A shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if
any court of competent jurisdiction finds that any restriction contained in this Appendix A is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other
restrictions contained herein. 
 (i) The period of time during which the provisions of this Appendix shall be in effect shall
be extended by the length of time during which Advisor is in breach of the terms hereof as determined by any court of competent jurisdiction on the Company’s application for injunctive relief. 

  
 A-3EX-10.29

 Exhibit 10.29 
 [Execution Copy] 
 EMPLOYMENT AGREEMENT 

(John G. Figueroa) 
 EMPLOYMENT AGREEMENT (this “Agreement”) dated November 29, 2012 by and between Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and John G. Figueroa
(“Executive”). 
 WHEREAS, commencing on the Effective Date, the Company and its subsidiaries and the Company’s
parent, Apria Holdings LLC, a Delaware limited liability company (“Holdings”), desire to employ Executive and desire to enter into an agreement embodying the terms of such employment; 

WHEREAS, Executive desires to be employed by the Company and Holdings, on the terms and subject to the conditions more fully set forth in
this Agreement; 
 NOW THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable
consideration, the parties agree as follows: 
 1. Term of Employment. Subject to the provisions of Section 7 of
this Agreement, Executive shall be employed by the Company and certain of its affiliates for a period commencing on November 29, 2012 (or such earlier date as agreed between the Company and Executive, the “Effective Date”) and ending
on the fifth anniversary of the Effective Date (the “Employment Term”), on the terms and subject to the conditions set forth in this Agreement; provided, however, that commencing on such fifth anniversary and on each
anniversary thereafter (each an “Extension Date”), the Employment Term shall be automatically extended for an additional one-year period, unless the Company or Executive provides the other party hereto 60 days prior Notice before the next
Extension Date that the Employment Term shall not be so extended. 
 2. Position. 

(a) During the Employment Term, Executive shall serve (i) as the Chief Executive Officer of the Company and Holdings,
(ii) subject to the vote of applicable equityholders, as a member of the Company and Holdings’ boards of directors and (iii) unless otherwise determined by the board of directors of the Company (the “Board”), as Chairman of
the Board. In such position, Executive shall report directly to the Board and shall have such duties and authority as shall be determined from time to time by the Board consistent with such title, duties and responsibilities, including reporting
responsibilities. 
 (b) During the Employment Term, Executive will devote Executive’s business time and best efforts to
the performance of Executive’s duties hereunder and will not engage in any other business, profession or occupation for compensation or otherwise which would conflict or materially interfere with the rendition of such services either directly
or indirectly, without the prior written consent of the Board; provided that nothing herein shall preclude Executive, (i) from engaging in charitable and civic activities, including accepting appointment to or continuing to serve on any
board of directors or trustees of any charitable organization or (ii)

  
 1 

 
from continuing to, or subject to the prior approval of the Board (which shall not be unreasonably withheld), from accepting appointment to serve on any board of directors or trustees of any
business corporation; provided in each case, and in the aggregate, that such activities do not conflict or interfere with the performance of Executive’s duties hereunder or conflict with Section 8. Executive currently serves on the
boards of Reliance Steel and Aluminum Company 
 (c) Executive’s principal work location will be in the Denver metropolitan
area and he will be required to, no later than July, 2013, relocate his principal residence to the Denver metropolitan area. Executive shall be entitled to reimbursement by the Company of all reasonable and customary out-of-pocket expenses
associated with relocating Executive’s family residence from the Cincinnati, Ohio area to Denver, Colorado, including all reasonable closing costs associated with the sale of the residence in Ohio (including, but not limited to, reasonable real
estate commission, survey, title insurance, attorney’s fees); all reasonable closing costs associated with the purchase of a residence in the Denver area (including, but not limited to, reasonable inspections, attorney fees, survey, title
insurance, and mortgage-related fees and reasonable expenses such as points, processing fees, underwriting fees, application and appraisal fees); the packing and movement of household goods and vehicles; transportation and hotel and food expenses
for Executive and his spouse associated with up to two (2) house-hunting trips to Denver; and reasonable temporary living in Denver and commuting expenses from San Francisco incurred during transition for up to seven months following the
Effective Date, and, without limiting the foregoing, in accordance with the Company’s policies and procedures governing relocation of executives. To the extent than any reimbursements under this Section 2(c) result in taxable income to
Executive, then Executive shall be fully grossed-up for applicable federal, state and local taxes upon such reimbursements. The Company’s headquarters is expected to remain in the greater Los Angeles metropolitan area. 

3. Compensation. 
 (a) Base Salary. During the Employment Term, the Company shall pay Executive a base salary at the annual rate of $750,000, payable in each case in regular installments in accordance with the
Company’s usual payment practices. Executive shall be entitled to such increases in Executive’s base salary, if any, as may be determined from time to time in the sole discretion of the Board. Executive’s annual base salary, as in
effect from time to time, is hereinafter referred to as the “Base Salary.” Executive shall receive performance reviews from the Board on a no less than annual basis. 
 (b) Annual Bonus. During each full fiscal year during the Employment Term, Executive shall be eligible to earn an annual bonus award (an “Annual Bonus”) in such amount, if any, as may be
determined in the sole discretion of the Board, calculated in accordance with the Company’s annual bonus plan from time to time and based on the achievement of performance objectives and targets adopted by the Board after consultation with
Executive. With respect to each full fiscal year during the Employment Term, Executive shall be eligible to earn a target Annual 

  
 2 

 
Bonus of not less than 100 percent (100%) of Executive’s Base Salary (the “Target Annual Bonus”) and a maximum Annual Bonus of not less than 200 percent (200%) of
Executive’s Base Salary. The Annual Bonus, if any, shall be paid to Executive within two and one-half (2.5) months after the end of the applicable fiscal year. 
 4. Equity Arrangements. Simultaneously with the execution of this Agreement, Holdings is entering into arrangements with regard to Executive’s equity arrangements with Holdings. 

5. Employee Benefits. During the Employment Term, Executive shall be entitled to participate in the Company’s employee
benefit plans (other than annual bonus and incentive plans) as in effect from time to time (collectively “Employee Benefits”), on the same basis as those benefits are generally made available to other senior executives of the Company.

 6. Business Expenses. During the Employment Term and in accordance with Company policy, Executive shall be entitled to
be reimbursed for reasonable and customary business expenses incurred by Executive in connection with the performance of Executive’s duties hereunder. 
 7. Termination. The Employment Term and Executive’s employment hereunder may be terminated by the Company at any time and for any reason upon Notice to Executive and by Executive upon at least
60 days’ advance Notice of any such resignation of Executive’s employment, other than as a result of Executive’s death. Notwithstanding any other provision of this Agreement, the provisions of this Section 7 shall exclusively
govern Executive’s rights upon termination of employment with the Company and its affiliates. 
 (a) By the Company with
Cause or By Executive Other Than as a Result of a Constructive Termination. 
 (i) The Employment Term and Executive’s
employment hereunder may be terminated by the Company with Cause and shall terminate automatically upon the effective date of Executive’s resignation other than as result of a Constructive Termination (as defined in Section 7(c)(ii)).

 (ii) For purposes of this Agreement, “Cause” shall mean Executive has (i) committed willful misconduct in the
performance of his duties hereunder; (ii) engaged in or committed theft, fraud or other illegal conduct; (iii) willfully failed to substantially perform his duties for a 30-day period after written demand for substantial performance that
refers to this paragraph and is delivered by the Company that specifically identifies the manner in which the Company believes Executive has not substantially performed his duties and provides reasonable instructions on how the Executive can
substantially perform his duties (this subsection (iii) will not apply to any failure resulting from the Executive’s complete or partial incapacity due to 

  
 3 

 
demonstrable physical illness or disability); (iv) refused or demonstrated an unwillingness to reasonably cooperate in good faith with any Company or government investigation or provide
testimony therein (other than such failure resulting from Executive’s disability); (v) willfully committed substantial and material insubordination in response to clear instructions from the Board; (vi) engaged in or committed any
willful act that is likely to and which does in fact have the effect of injuring the reputation or business of the Company; (vii) willfully violated his fiduciary duty or his duty of loyalty to the Company or the Company’s Code of Ethical
Business Conduct in any material respect; (viii) used alcohol or drugs (other than drugs prescribed to Executive by a physician and used by Executive for their intended purpose for which they had been prescribed) in a manner which materially
and repeatedly interferes with the performance of his duties hereunder or which has the effect of materially injuring the reputation or business of the Company; or (ix) engaged in or committed a material breach of this Agreement for a 30-day
period after written notification is delivered by the Company that specifically refers to this paragraph and identifies the manner in which the Company believes Executive has materially breached this Agreement. In no event shall the Executive be
considered to have been terminated for “Cause” unless the Company delivers a written notice of termination to the Executive identifying in reasonable detail the acts or omissions constituting “Cause” and the provision of this
Agreement relied upon. For the avoidance of doubt, mere failure of the Company to achieve any performance goals shall not constitute “Cause.” For purposes of the foregoing sentence of this paragraph, no act, or failure to act, on
Executive’s part shall be considered willful unless done or omitted to be done, by him not in good faith or without reasonable belief that his action or omission was in the best interest of the Company. Notwithstanding the foregoing, Executive
shall not be deemed to have been terminated for Cause without delivery to Executive of a notice of termination approved by a majority of the Board (other than Executive) stating that in the good faith opinion of the required majority of the Board
(other than Executive), Executive has engaged in or committed conduct of the nature described in this paragraph, and specifying the particulars thereof in detail. 
 (iii) If Executive’s employment is terminated by the Company with Cause, or if Executive resigns other than as a result of a Constructive Termination, Executive shall be entitled to receive:

 (A) the Base Salary accrued through the date of termination, payable within fifteen days following the date of
such termination; 
 (B) any Annual Bonus in respect of the immediately preceding fiscal year if not previously
paid, which Annual Bonus shall be payable in accordance with Section 3(b) so long as Executive’s employment was not terminated by the Company with Cause (except to the extent payment is otherwise deferred pursuant to any applicable
deferred compensation arrangement with the Company, in which case such amount shall be paid in full at the earliest such time as is provided under such arrangement); and 

(C) such fully vested and non-forfeitable Employee Benefits, if any, as to which Executive may be entitled under the
employee benefit plans of the Company (the amounts described in clauses (A) through (C) hereof being referred to as the “Accrued Rights”). 

  
 4 

 Following such termination of Executive’s employment by the Company with Cause or
resignation by Executive other than as a result of a Constructive Termination, except as set forth in this Section 7(a)(iii), Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

(b) Disability or Death. 
 (i) The Employment Term and Executive’s employment hereunder shall terminate upon Executive’s death and may be terminated by the Company if Executive becomes physically or mentally
incapacitated, after providing Executive reasonable accommodation, and is therefore unable, for a period of six consecutive months or for an aggregate of twelve months in any twenty-four consecutive month period, to perform Executive’s duties.
The period of six months shall be deemed continuous unless Executive returns to work for a period of at least 30 consecutive days during such period and competently performs his job duties and responsibilities during such period. Such incapacity is
hereinafter referred to as “Disability”. Any question as to the existence of the Disability of Executive as to which Executive and the Company cannot agree shall be determined in writing by a qualified independent physician mutually
acceptable to Executive and the Company. If Executive and the Company cannot agree as to a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third qualified independent physician which third
such physician shall make such determination. The determination of Disability made by such physician in writing to the Company and Executive shall be final and conclusive for all purposes of the Agreement and any other agreement between the Company
and Executive that incorporates the definition of “Disability”. 
 (ii) Upon termination of Executive’s
employment hereunder for either Disability or death, Executive or Executive’s estate (as the case may be) shall be entitled to receive: 
 (A) the Accrued Rights; and 
 (B) a pro rata portion of an Annual
Bonus (if otherwise payable in accordance with Section 3(c)), payable within 30 days after annual bonuses in respect of the year of termination are generally paid to senior executives of the Company, based upon the percentage of the fiscal year
that shall have elapsed through the date of Executive’s termination of employment; 
 Following Executive’s
termination of employment due to death or Disability, except as set forth in this Section 7(b)(ii), Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

(c) By the Company without Cause or Resignation by Executive as a result of Constructive Termination. 

(i) The Employment Term and Executive’s employment hereunder may be terminated by the Company without Cause or by Executive as a
result of a Constructive Termination. 

  
 5 

 (ii) For purposes of this Agreement, a “Constructive
Termination” shall be deemed to have occurred upon (A) the failure of the Company to pay or provide or cause to be paid or provided Executive’s Base Salary or Annual Bonus (if any) when due hereunder or any reduction in Base Salary or
Target Annual Bonus (as a percentage of Base Salary); (B) a relocation of Executive’s principal place of business which will result in an increase by more than fifty (50) miles in Executive’s one-way commute; (C) a reduction
in Executive’s title or a material reduction in the nature, status and scope of Executive’s authorities, duties and responsibilities (measured in the aggregate); (D) Executive not being promptly appointed to the Board following the
Effective Date or Executive being involuntarily removed from the Board during the Term; (E) the failure of a successor employer to the Company to assume this Agreement in writing; (F) the Company’s delivery of a Notice pursuant to
Section 1 to not extend the Employment Term; or (G) Executive’s not being the Chief Executive Officer of the operating entity following the occurrence of a Change of Control (as defined in the Securityholders Agreement, among Holdings
and the other parties thereto (including Executive)); provided that (i) the events described in this Section 7(c)(ii) shall constitute a Constructive Termination only if the Company fails to cure such event within 30 days after
Notice is given by Executive specifying in reasonable detail the event which constitutes Constructive Termination, (ii) any acquisition, combination, joint venture, divestiture or separation of one or more business lines or assets of the
Company and its subsidiaries shall not give rise to “Constructive Termination” under clauses (B)-(G) if Executive continues to be the Chief Executive Officer of the portion of the business that includes the Company’s infusion
businesses and (iii) “Constructive Termination” shall cease to exist for an event on the 90th day following the later of its occurrence or Executive’s knowledge thereof, unless Executive has given the Company Notice thereof prior to such date. 

(iii) If Executive’s employment is terminated by the Company without Cause (other than by reason of death or Disability) or if
Executive resigns as a result of a Constructive Termination, Executive shall be entitled to receive: 
 (A) the
Accrued Rights; 
 (B) a pro rata portion of an Annual Bonus (if otherwise payable in accordance with
Section 3(c)), payable within 30 days after annual bonuses in respect of the year of termination are generally paid to senior executives of the Company, based upon the percentage of the fiscal year that shall have elapsed through the date of
Executive’s termination of employment; 
 (C) subject to Executive’s compliance with the provisions of
Sections 8 and 9, the payment of an aggregate amount equal to the product of (x) two and (y) the sum of (1) the annual Base Salary amount plus (2) an amount equal to (a) if the employment termination occurs on or prior to
December 31, 2014, the Target Annual Bonus or (b) if the employment termination occurs after December 31, 2014, the average of Executive’s Annual Bonuses payable pursuant to Section 3(b) for the immediately preceding two
fiscal years, which aggregate amount shall be payable to Executive in equal installments in accordance with the Company’s normal payroll practices, as in effect on the date of the termination of Executive’s employment, over twenty-four
months after the date of such termination; 

  
 6 

 provided that the aggregate amount described in this clause (C) shall be reduced
by the present value of any other cash severance benefits payable to Executive under any other plans, programs or arrangements of the Company or its affiliates; and 

(D) a lump sum payment equal to 24 times the monthly cost of COBRA continuation coverage under the Company’s group
health plans. 
 Amounts payable to Executive under subparagraphs (B), (C) and (D), above, are subject
to Executive providing a release of all claims to the Company in the form attached hereto as Exhibit A (with any changes necessary to comply with applicable law and/or make the release legally enforceable in the reasonable judgment of the Company)
no later than the 59th day following termination of
employment (and the Company may, at its sole election, defer the payment of any such amount until the 60th day following termination of employment). Following Executive’s termination of employment by the Company without Cause (other than by reason of Executive’s death or Disability) or by
Executive’s resignation as a result of a Constructive Termination, except as set forth in this Section 7(c)(iii), Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

(d) Expiration of Employment Term. 
 (i) Election Not to Extend the Employment Term. In the event either party elects not to extend the Employment Term pursuant to Section 1, unless Executive’s employment is terminated
pursuant to paragraphs (a), (b) or (c) of this Section 7, Executive’s termination of employment hereunder (whether or not Executive continues as an employee of the Company thereafter) shall be deemed to occur on the close of
business on the day immediately preceding the next scheduled Extension Date and Executive shall be entitled to receive the Accrued Rights. Following such termination of Executive’s employment hereunder as a result of either party’s
election not to extend the Employment Term, except as set forth in this Section 7(d)(i) and subject to the provisions of paragraphs (a), (b) or (c) of this Section 7 as may apply, Executive shall have no further rights to any
compensation or any other benefits under this Agreement. 
 (ii) Continued Employment Beyond the Expiration of the Employment
Term. Unless the parties otherwise agree in writing, continuation of Executive’s employment with the Company beyond the expiration of the Employment Term shall be deemed an employment at-will and shall not be deemed to extend any of the
provisions of this Agreement and Executive’s employment may thereafter be terminated at will by either Executive or the Company; provided, that the provisions of Sections 8, 9 and 10 of this Agreement, and any accrued and vested rights
of Executive as of the last day of the Employment Term, shall survive any termination of this Agreement or Executive’s termination of employment hereunder. 
 (e) Notice of Termination. Any purported termination of employment by the Company or by Executive (other than due to Executive’s death) shall be communicated by Notice of Termination to the
other party hereto in accordance with Section 11(i) hereof. For purposes of this Agreement, a “Notice of Termination” shall mean a Notice which shall indicate 

  
 7 

 
the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of employment
under the provision so indicated. 
 (f) Board/Committee Resignation. Upon termination of Executive’s employment for
any reason, Executive agrees to resign, as of the date of such termination and to the extent applicable, from the Board (and any committees thereof) and the board of directors (and any committees thereof) of any of the Company’s affiliates.

 8. Non-Competition. 
 (a) Executive acknowledges and recognizes the highly competitive nature of the businesses of the Company and its affiliates and accordingly agrees as follows: 

(i) Executive will not, within twenty-four months following the termination of Executive’s employment with the
Company (the “Post-Termination Period”) or during the Employment Term (collectively with the Post-Termination Period, the “Restricted Period”), accept an employment or consulting relationship (or own or have any financial
interest in), directly or indirectly, with any entity which derives at least 10% of its revenue from engaging in the business of home respiratory therapy, home infusion therapy, and home medical equipment that is competitive with the Company and its
subsidiaries within the United States (a “Competitive Business”). 
 (ii) During the Restricted Period,
Executive will not initiate or respond to communications with any of the employees of the Company or its subsidiaries who earned annually $50,000 or more as a Company or subsidiary employee during the twelve-month period prior to the termination of
such employee’s employment with the Company, for the purpose of soliciting such employee, or facilitating the hiring of any such employee, to work for any other business, individual, partnership, firm, corporation, or other entity. 

(iii) During the Restricted Period, Executive will not influence or attempt to influence customers of the Company or its
subsidiaries or any of its present or future subsidiaries or affiliates, either directly or indirectly, to divert their business to any individual, partnership, firm, corporation or other entity then in competition with the business of the Company
or any subsidiary or affiliate of the Company. 
 (iv) During the Restricted Period, Executive will not, other
than as required by law or by order of a court or other competent authority, make or publish, or cause any other person to make or publish, any statement that is disparaging or that reflects negatively upon the Company or its affiliates, or that is
or reasonably would be expected to be damaging to the reputation of the Company or its affiliates. 
 Notwithstanding anything to
the contrary in this Agreement, Executive may, directly or indirectly own, solely as an investment, securities of any person engaged in a Competitive Business which are publicly traded on a national or regional stock exchange

  
 8 

 
or on the over-the-counter market if Executive (i) is not a controlling person of, or a member of a group which controls, such person and (ii) does not, directly or indirectly, own 5%
or more of any class of securities of such person. 
 (b) It is expressly understood and agreed that although Executive and the
Company consider the restrictions contained in this Section 8 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction, that the time or territory or any other restriction contained in this Agreement is
an unenforceable restriction against Executive, the provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine
or indicate to be enforceable. Alternatively, if any court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not
affect the enforceability of any of the other restrictions contained herein. 
 (c) The period of time during which the
provisions of this Section 8 shall be in effect shall be extended by the length of time during which Executive is in breach of the terms hereof as determined by any court of competent jurisdiction on the Company’s application for
injunctive relief. 
 9. Confidentiality. 
 (a) Executive will not at any time (whether during or after Executive’s employment with the Company) (x) retain or use for the benefit, purposes or account of Executive or any other person; or
(y) disclose, divulge, reveal, communicate, share, transfer or provide access to any person outside the Company (other than its professional advisers who are bound by confidentiality obligations), any non-public, proprietary or confidential
information — including without limitation trade secrets, know-how, research and development, software, databases, inventions, processes, formulae, technology, designs and other intellectual property, information concerning finances,
investments, profits, pricing, costs, products, services, vendors, customers, clients, partners, investors, personnel, compensation, recruiting, training, advertising, sales, marketing, promotions, government and regulatory activities and approvals
— concerning the past, current or future business, activities and operations of the Company, its subsidiaries or affiliates and/or any third party that has disclosed or provided any of same to the Company on a confidential basis
(“Confidential Information”) without the prior written authorization of the Board. 
 (b) “Confidential
Information” shall not include any information that is (a) a matter of public knowledge; (b) is independently developed by a person not a party to this Agreement without the use, directly or indirectly, of Company information;
(c) was in Executive’s possession prior to providing services for the Company, provided that said information was not obtained from the Company; (d) is information of a general nature that could reasonably be acquired by Executive if
employed by a similar business as Company; (e) is obtained by Executive from a third party not subject to any confidentiality obligation to the Company; or (f) is required to be disclosed by law or the order of any court or governmental

  
 9 

 
agency, or in any litigation or similar proceeding; provided that prior to making any such required disclosure, Executive shall notify the Company in sufficient time to permit the Company to seek
an appropriate protective order. 
 (c) Except as required by law, Executive will not disclose to anyone, other than
Executive’s immediate family and legal or financial advisors, the existence or contents of this Agreement; provided, that Executive may disclose to any prospective future employer the notice provisions of Sections 8 and 9 of this
Agreement provided they agree to maintain the confidentiality of such terms. 
 (d) Upon termination of Executive’s
employment with the Company for any reason, Executive shall (x) cease and not thereafter commence use of any Confidential Information or intellectual property (including without limitation, any patent, invention, copyright, trade secret,
trademark, trade name, logo, domain name or other source indicator) owned or used by the Company, its subsidiaries or affiliates; (y) immediately destroy, delete, or return to the Company, at the Company’s option, all originals and copies
in any form or medium (including memoranda, books, papers, plans, computer files, letters and other data) in Executive’s possession or control (including any of the foregoing stored or located in Executive’s office, home, laptop or other
computer, whether or not Company property) that contain Confidential Information or otherwise relate to the business of the Company, its affiliates and subsidiaries, except that Executive may retain only those portions of any personal notes,
notebooks and diaries that do not contain any Confidential Information and Executive’s rolodex (or other physical or electronic address book); and (z) fully cooperate with the Company regarding the delivery or destruction of any other
Confidential Information not within Executive’s possession or control of which Executive is or becomes aware. Notwithstanding the foregoing, Executive may retain Executive’s rolodex and similar address books. To the extent that Executive
is provided with a cell phone number by the Company during employment, the Company shall cooperate with Executive in transferring such cell phone number to Executive’s individual name following termination. 

(e) The provisions of Section 8, 9 and 10 shall survive the termination of Executive’s employment for any reason. 

10. Specific Performance. Executive acknowledges and agrees that the Company’s remedies at law for a breach or threatened
breach of any of the provisions of Sections 8 or 9 would be inadequate and the Company would suffer irreparable damages as a result of such breach or threatened breach. In recognition of this fact, Executive agrees that, in the event of such a
breach or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be entitled to seek a temporary or permanent injunction or any other equitable remedy which may then be available. 

11. Miscellaneous. 
 (a) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Colorado (provided that if Executive’s principal place of

  
 10 

 
employment is moved to another state, then such state’s laws shall apply for so long as such principal place of employment is located in such state), without regard to conflicts of laws
principles thereof that would direct the application of the laws of any other jurisdiction. 
 (b) Entire
Agreement/Amendments. This Agreement contains the entire understanding of the parties with respect to the employment of Executive by the Company. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the
parties with respect to the subject matter herein other than those expressly set forth herein. This Agreement may not be altered, modified, or amended except by written instrument signed by the parties hereto. In the event of any inconsistency
between this Agreement and any other plan, program, practice or agreement of which Executive is a participant or a party, this Agreement shall control unless such other plan, program, practice or agreement specifically refers to the provisions of
this sentence. 
 (c) No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on
any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. 

(d) Severability. In the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected thereby. 
 (e) Assignment. This Agreement, and all of the respective parties rights and duties hereunder, shall be assignable or delegable only pursuant to a written agreement executed by both parties hereto.
Upon such assignment, the rights and obligations of the respective parties hereunder shall become the rights and obligations of such affiliate or successor person or entity. 
 (f) Set Off; No Mitigation. The Company’s obligation to pay Executive the amounts provided and to make the arrangements provided hereunder shall be subject to set-off, counterclaim or
recoupment of amounts owed by Executive to the Company or its affiliates. Executive shall not be required to mitigate the amount of any payment provided for pursuant to this Agreement by seeking other employment, and such payments shall not be
reduced by any compensation or benefits received from any subsequent employer or other endeavor. 
 (g) Compliance with IRC
Section 409A. The intent of the parties is that payments and benefits under this Agreement comply with Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”) to the extent subject thereto, and,
accordingly, to the maximum extent permitted, this Agreement shall be interpreted and administered to be in compliance therewith. Notwithstanding anything herein to the contrary, (i) if at the time of Executive’s termination of employment
with the Company, Executive is a “specified employee” as defined in Section 409A and the deferral of the commencement of any payments or benefits otherwise payable hereunder as a result of such termination of employment is necessary
in order to prevent any accelerated or additional tax under Section 409A, then the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid
or provided to Executive) until the date 

  
 11 

 
that is six months following Executive’s termination of employment with the Company (or the earliest date as is permitted under Section 409A) (the “Delay Period”), and
(ii) if any other payments of money or other benefits due to Executive hereunder could cause the application of an accelerated or additional tax under Section 409A, such payments or other benefits shall be deferred if deferral will make
such payment or other benefits compliant under Section 409A, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Board in consultation with Executive, that does not cause
such an accelerated or additional tax. To the extent required to avoid an accelerated or additional tax under Section 409A, amounts reimbursable to Executive under this Agreement shall be paid to Executive on or before the last day of the year
following the year in which the expense was incurred and the amount of expenses eligible for reimbursement (and in-kind benefits provided to Executive) during any one year may not effect amounts reimbursable or provided in any subsequent year;
provided, however, that with respect to any reimbursements for any taxes which Executive would become entitled to under the terms of this Agreement, the payment of such reimbursements shall be made by the Company no later than the end
of the calendar year following the calendar year in which Executive remits the related taxes. The Company shall consult with Executive in good faith regarding the implementation of the provisions of this Section 11(g); provided that neither the
Company nor any of its employees or representatives shall have any liability to Executive with respect to thereto. 
 (h)
Successors; Binding Agreement. This Agreement shall inure to the benefit of and be binding upon personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. In the event of
Executive’s death prior to receipt of all amounts payable to Executive (including any unpaid amounts due under Section 7), such amounts shall be paid to Executive’s beneficiary designated by him by Notice to the Company or, in the
absence of such designation, to Executive’s estate. 
 (i) Notice. For the purpose of this Agreement, notices and
all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three postal delivery days after it has been mailed by United States registered
mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth below in this Agreement, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that Notice
of change of address shall be effective only upon receipt (each such communication, “Notice”). 
 If to the
Company, addressed to: 
 Apria Healthcare Group Inc. 
 26220 Enterprise Court 
 Lake Forest, California 92630 

Attention: General Counsel 

  
 12 

 with a copy which shall not constitute Notice to: 

The Blackstone Group 
 345 Park Avenue 
 New York, New York 10154 

Attention: Neil P. Simpkins 
 with a copy which shall not constitute Notice to: 
 Simpson Thacher &
Bartlett LLP 
 425 Lexington Ave. 
 New York, NY 10017 
 Attention: Gregory Grogan 

If to Executive, to the most recent address of Executive set forth in the personnel records of the Company, with a copy which shall not
constitute Notice to: 
 Finck & Dadras LLP 
 100 Spear Street, Suite 700 
 San Francisco, CA 94105 

Attention: Kevin W. Finck 
 (j) Executive Representation. Executive hereby represents to the Company that, to the best of Executive’s knowledge, the execution and delivery of this Agreement by Executive and the Company
and the performance by Executive of Executive’s duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any employment agreement or other agreement or policy to which Executive is a party or otherwise bound,
including any prior employment agreement or separation agreement with another employer of Executive. The Company acknowledges that it has received and reviewed the Separation Agreement between Executive and Omnicare, Inc., including the non-compete
provisions contained therein, and, to the best of the Company’s knowledge, Executive’s position as currently contemplated by the Board would not violate said provisions. 

(k) Prior Agreements. This Agreement supersedes all prior agreements and understandings (including verbal agreements) between
Executive and the Company and/or its affiliates regarding the terms and conditions of Executive’s employment with the Company and/or its affiliates. 
 (l) Indemnification and Enforcement Costs. The Company shall indemnify and hold harmless Executive for all claims asserted against Executive as an employee or director of the Company to the fullest
extent permitted by the Company’s charter, by-laws and applicable law. The Company shall also maintain and cover Executive under one or more contract(s) of directors’ and officers’ liability insurance both during and, while potential
liability exists, after the term of this Agreement and Executive’s employment, to the same extent as the Company covers its other officers and directors. The Company shall engage and pay legal counsel selected by it (but reasonably satisfactory
to Executive) to defend or prosecute any claims involving Executive (whether initiated by Executive or a third party) with respect to Executive’s rights and obligations under the agreement referenced in Section 11(j); provided that the
Company’s total costs for legal counsel shall be subject to the cap previously communicated in writing between 

  
 13 

 
counsel to the Executive and Company counsel and any litigation counsel shall jointly represent the Company and Executive to the extent the interests of Executive and the Company are not in
conflict (in the judgment of such counsel) (provided further that to the extent there are conflicts that are not waived by the parties, the Company shall retain separate counsel at its expense). In the event of the bringing of any action,
proceeding, arbitration or suit by a party hereto against another party hereunder by reason of any breach of any of the covenants, agreements, or provisions arising out of this Agreement, the prevailing party shall be entitled to recover all
reasonable costs and expenses of that action or suit, or at trial, arbitration or on appeal, and in collection of judgment, including reasonable attorneys’ fees, accounting, and other professional fees resulting therefrom. 

(m) Cooperation. Executive shall provide Executive’s reasonable cooperation in connection with any action or proceeding (or
any appeal from any action or proceeding) which relates to events occurring during Executive’s employment with the Company and its affiliates. This provision shall survive any termination of this Agreement. 

(n) Withholding Taxes. The Company may withhold from any amounts payable under this Agreement such Federal, state and local taxes
as may be required to be withheld pursuant to any applicable law or regulation. 
 (o) Counterparts. This Agreement may
be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 
 [Signature Page Follows this Page] 

  
 14 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Employment Agreement as of
the day and year first above written. 
  

	
	APRIA HEALTHCARE GROUP INC.
	
	  

	By:
	Title:
	
	EXECUTIVE
	
	  

	JOHN G. FIGUEROA

 EXHIBIT A 
 RELEASE OF CLAIMS 
 This Release of Claims is entered into by John
G. Figueroa (“Executive”). 
 WHEREAS, Executive and Apria Healthcare Group Inc. with offices at
                     (the “Company”) entered into an Employment Agreement (the “Employment Agreement”) dated November 29,
2012 that provides Executive certain severance and other benefits in the event of an involuntary termination of Executive’s employment without Cause or Executive’s resignation of employment due to a Constructive Termination (each term as
defined under the Employment Agreement); 
 WHEREAS, Executive’s employment has so terminated; and 

WHEREAS, pursuant to Section 7(c)(iii) of the Employment Agreement, a condition of Executive’s entitlement to certain severance
and other benefits thereunder is his agreement to this Release of Claims. 
 NOW, THEREFORE, in consideration of the severance
and other benefits provided under Section 7(c)(iii)(B), (C) and (D) of the Employment Agreement, Executive agrees as follows: 
 1. Executive, for himself and his heirs, executors and administrators, hereby fully and finally waives, discharges and releases the Company, including each of the Company’s past, current and future
parents, subsidiaries, and affiliates, and its and their shareholders, members, directors, officers, and employees (“Released Parties”), from any and all claims arising on or prior to the date hereof relating to his employment with the
Company or his termination therefrom, whether now known or later discovered, which he or anyone acting on his behalf might otherwise have had or asserted, including, but not limited to, any express or implied contract of employment claims, any tort
claims, claims under Title VII of the Civil Rights Act of 1964, as amended, the Family and Medical Leave Act of 1993, Section 1981 of the Civil Rights Act of 1866, the Age Discrimination in Employment Act of 1967, as amended, Americans with
Disabilities Act of 1991, as amended, the Older Workers Benefit Protection Act of 1990, the Worker Adjustment and Retraining Notification Act, the laws, including the labor laws of any state, and all claims under related common law, statutes, and
executive orders at the federal, state and local levels of government, and any claims to any benefits from employment with the Company, including, but not limited to, claims for salary, bonuses, unvested stock options, severance pay, vacation pay or
any benefits under the Employee Retirement Income Security Act of 1974, as amended, other than: (i) those benefits set forth in Section 7(c)(iii) of the Employment Agreement, (ii) all rights and benefits as a member of the Company or
as the holder of any equity security or any other equity interest in the Company, and (iii) any claims for accrued and vested benefits under any of the Company’s employee retirement and welfare benefit plans. In addition, Executive
represents that no incident has occurred during his employment with the Company that could form the basis for any claim by him against the Company under the worker’s compensation laws of any jurisdiction. For the avoidance of

 
doubt, the foregoing does not constitute a release of any claims of Executive in respect of his direct and indirect holdings of equity in the Company and its affiliates or any other claims of
Executive under any other written agreement that is not related to Executive’s employment and is between Executive or any of his affiliates and the Company and any of its affiliates. 

2. Executive affirms that he has read the following quotation of the language of Section 1542 of the California Civil Code, which
states in full: 
 A general release does not extend to claims which the creditor does not know or suspect to exist in his favor
at the time of executing the release, which if known by him must have materially affected his settlement with the debtor. 

Executive expressly waives any rights that he may have under Section 1542 to the full extent that he may lawfully waive such rights
pertaining to a general release of claims, and he affirms that he releases all known or unknown claims that he have or may have against the Company or any of the Released Parties as stated in this Release of Claims. 

3. Executive represents that he has not brought any charges, claims, demands, suits or actions, known or unknown, in any forum,
against the Released Parties related to his employment or his termination (excluding any claims of Executive in respect of his direct and indirect holdings of equity in the Company and its affiliates or any other claims of Executive under any other
written agreement that is not related to Executive’s employment and is between Executive or any of his affiliates and the Company and any of its affiliates); provided, however, that Executive shall not be prevented from enforcing any
rights he may have under the terms of this Release of Claims or in respect of any claims of Executive in respect of his direct and indirect holdings of equity in the Company and its affiliates or any other claims of Executive under any other written
agreement that is not related to Executive’s employment and is between Executive or any of his affiliates and the Company and any of its affiliates.  
 4. Executive acknowledges that he is subject to a confidentiality covenant pursuant to Section 9 of the Employment Agreement and a noncompetition and non-solicitation covenant pursuant to
Section 8 of the Employment Agreement and hereby reaffirms his obligations thereunder. 
 5. EXECUTIVE ACKNOWLEDGES THAT HE
HAS BEEN ADVISED, IN WRITING, TO CONSULT WITH AN ATTORNEY OF HIS CHOICE PRIOR TO SIGNING THIS AGREEMENT AND THAT HE HAS SIGNED THIS AGREEMENT KNOWINGLY, VOLUNTARILY, AND FREELY, AND WITH SUCH COUNSEL AS HE DEEMED APPROPRIATE. IN ADDITION, EMPLOYEE
ACKNOWLEDGES THAT HE HAS BEEN PROVIDED WITH A PERIOD OF UP TO TWENTY-ONE (21) DAYS IN WHICH TO CONSIDER WHETHER OR NOT TO ENTER INTO THIS RELEASE. FURTHER, EMPLOYEE ACKNOWLEDGES THAT HE HAS BEEN ADVISED OF HIS RIGHT TO REVOKE THIS AGREEMENT
DURING THE SEVEN (7) DAY PERIOD FOLLOWING EXECUTION HEREOF, AND THAT THE AGREEMENT SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED. 

 6. Nothing contained herein shall be construed as an admission by the Company of any
liability of any kind to Executive, all such liability being expressly denied except for obligations of the Company imposed by the Employment Agreement which survive pursuant to this Release of Claims. 

 

	
	  

	John G. Figueroa

  

	
	Date:                     , 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]